glp 1 monoclonal antibody Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R
Description
It is an exciting time for patients and providers alike, and I am hopeful these advances will continue to improve access, affordability, and long-term outcomes
Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat Type 2 diabetes, is the nation's top-selling drug
In 2024, the FDA updated Ozempics label to warn of a risk of pulmonary aspiration in patients who undergo procedures or surgeries requiring deep sedation or anesthesia
These are all big safety concerns, no matter what the product itself is. Additional reporting by Rachel de Leon
